Ira Louis Lazar, MD | |
1905 Clint Moore Rd, Ste 212, Boca Raton, FL 33496 | |
(561) 989-9070 | |
(561) 989-0255 |
Full Name | Ira Louis Lazar |
---|---|
Gender | Male |
Speciality | Nephrology |
Experience | 47 Years |
Location | 1905 Clint Moore Rd, Boca Raton, Florida |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1174554893 | NPI | - | NPPES |
068748100 | Medicaid | FL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RN0300X | Internal Medicine - Nephrology | 41886 (Florida) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Ara - Boca Raton Dialysis Llc | Boca raton, FL | Dialysis facility |
Boca Raton Regional Hospital | Boca raton, FL | Hospital |
Delray Medical Center | Delray beach, FL | Hospital |
Bethesda Hospital Inc | Boynton beach, FL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Florida Kidney Physicians Llc | 4385925650 | 140 |
News Archive
Luminex Corporation, the worldwide leader in multiplexed solutions, and High Throughput Genomics, Inc. (HTG), provider of the quantitative Nuclease Protection Assay (qNPA™), today launched a new custom gene expression product, the qBead Gene Expression Assay (qBead Assay). The companies co-developed the product and have signed an exclusive distribution agreement in which Luminex will begin offering it to the research community.
A technique for detecting prions in tissue, developed in recent years by UCSF scientists, is significantly more sensitive than the diagnostic procedures currently used to detect the lethal particles in samples of brain tissue from patients, according to a study performed by a UCSF team.
Noncombat-related injury-caused by regular car accidents, falls and burns-is the most common reason for pediatric admissions to U.S. military combat hospitals in both Iraq and Afghanistan reveals new study findings published in the May issue of the Journal of the American College of Surgeons.
Jennerex, Inc., a clinical-stage cancer biotherapeutics company, today reported positive results from its Phase 1 dose escalation study evaluating the intravenous administration of JX-594 to patients with metastatic cancer. The data presented today demonstrated clear dose-related delivery to solid tumors, cancer-targeted replication and gene expression, and anti-cancer effects of JX-594 delivered IV.
› Verified 5 days ago
Entity Name | South Florida Kidney Disease & Hypertension Specialists, Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1972618445 PECOS PAC ID: 1456355858 Enrollment ID: O20060928000121 |
News Archive
Luminex Corporation, the worldwide leader in multiplexed solutions, and High Throughput Genomics, Inc. (HTG), provider of the quantitative Nuclease Protection Assay (qNPA™), today launched a new custom gene expression product, the qBead Gene Expression Assay (qBead Assay). The companies co-developed the product and have signed an exclusive distribution agreement in which Luminex will begin offering it to the research community.
A technique for detecting prions in tissue, developed in recent years by UCSF scientists, is significantly more sensitive than the diagnostic procedures currently used to detect the lethal particles in samples of brain tissue from patients, according to a study performed by a UCSF team.
Noncombat-related injury-caused by regular car accidents, falls and burns-is the most common reason for pediatric admissions to U.S. military combat hospitals in both Iraq and Afghanistan reveals new study findings published in the May issue of the Journal of the American College of Surgeons.
Jennerex, Inc., a clinical-stage cancer biotherapeutics company, today reported positive results from its Phase 1 dose escalation study evaluating the intravenous administration of JX-594 to patients with metastatic cancer. The data presented today demonstrated clear dose-related delivery to solid tumors, cancer-targeted replication and gene expression, and anti-cancer effects of JX-594 delivered IV.
› Verified 5 days ago
Entity Name | Florida Kidney Physicians Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1760831564 PECOS PAC ID: 4385925650 Enrollment ID: O20161228000460 |
News Archive
Luminex Corporation, the worldwide leader in multiplexed solutions, and High Throughput Genomics, Inc. (HTG), provider of the quantitative Nuclease Protection Assay (qNPA™), today launched a new custom gene expression product, the qBead Gene Expression Assay (qBead Assay). The companies co-developed the product and have signed an exclusive distribution agreement in which Luminex will begin offering it to the research community.
A technique for detecting prions in tissue, developed in recent years by UCSF scientists, is significantly more sensitive than the diagnostic procedures currently used to detect the lethal particles in samples of brain tissue from patients, according to a study performed by a UCSF team.
Noncombat-related injury-caused by regular car accidents, falls and burns-is the most common reason for pediatric admissions to U.S. military combat hospitals in both Iraq and Afghanistan reveals new study findings published in the May issue of the Journal of the American College of Surgeons.
Jennerex, Inc., a clinical-stage cancer biotherapeutics company, today reported positive results from its Phase 1 dose escalation study evaluating the intravenous administration of JX-594 to patients with metastatic cancer. The data presented today demonstrated clear dose-related delivery to solid tumors, cancer-targeted replication and gene expression, and anti-cancer effects of JX-594 delivered IV.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Ira Louis Lazar, MD 1905 Clint Moore Rd, Ste 212, Boca Raton, FL 33496 Ph: (561) 989-9070 | Ira Louis Lazar, MD 1905 Clint Moore Rd, Ste 212, Boca Raton, FL 33496 Ph: (561) 989-9070 |
News Archive
Luminex Corporation, the worldwide leader in multiplexed solutions, and High Throughput Genomics, Inc. (HTG), provider of the quantitative Nuclease Protection Assay (qNPA™), today launched a new custom gene expression product, the qBead Gene Expression Assay (qBead Assay). The companies co-developed the product and have signed an exclusive distribution agreement in which Luminex will begin offering it to the research community.
A technique for detecting prions in tissue, developed in recent years by UCSF scientists, is significantly more sensitive than the diagnostic procedures currently used to detect the lethal particles in samples of brain tissue from patients, according to a study performed by a UCSF team.
Noncombat-related injury-caused by regular car accidents, falls and burns-is the most common reason for pediatric admissions to U.S. military combat hospitals in both Iraq and Afghanistan reveals new study findings published in the May issue of the Journal of the American College of Surgeons.
Jennerex, Inc., a clinical-stage cancer biotherapeutics company, today reported positive results from its Phase 1 dose escalation study evaluating the intravenous administration of JX-594 to patients with metastatic cancer. The data presented today demonstrated clear dose-related delivery to solid tumors, cancer-targeted replication and gene expression, and anti-cancer effects of JX-594 delivered IV.
› Verified 5 days ago
Dr. Craig Michael Brodsky, Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1000 Nw 9th Ct, Suite 201, Boca Raton, FL 33486 Phone: 561-395-4600 Fax: 561-395-6903 | |
Dr. Sandra Luz Hirsch, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 660 Glades Rd, Ste 300, Boca Raton, FL 33431 Phone: 561-620-8992 Fax: 561-620-5815 | |
Dr. David John Alley, MD Nephrology Medicare: Medicare Enrolled Practice Location: 660 Glades Rd, Suite 140, Boca Raton, FL 33431 Phone: 561-447-7737 Fax: 561-447-9022 | |
Mrs. Mushfeka Moiz Golawala, M.D Nephrology Medicare: Accepting Medicare Assignments Practice Location: 20384 Hacienda Ct, Boca Raton, FL 33498 Phone: 561-703-1383 Fax: 561-423-8372 | |
Mohamed Atef Mohamed Elmahdy Hamed, Nephrology Medicare: Medicare Enrolled Practice Location: 800 Meadows Rd, Boca Raton, FL 33486 Phone: 561-955-7100 | |
Craig L Stemmer, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2900 N Military Trl, Ste 195, Boca Raton, FL 33431 Phone: 561-241-7100 Fax: 561-241-3647 | |
Farid Assouad, Nephrology Medicare: Accepting Medicare Assignments Practice Location: 7777 Glades Rd, Ste 100, Boca Raton, FL 33434 Phone: 561-573-3495 Fax: 888-910-3040 |